Guangzhou JEEP Biotechnology: difference between revisions
Diff·revision 34 → 35·04:47, 8 Feb 2025
Difference between revision 34 and revision 35 of Guangzhou JEEP Biotechnology. 2 lines changed; the page grew by 420 bytes.
| Revision 34 — 09:25, 30 Jan 2025 PurityClaimPia (talk) add short description 7,911 bytes +27 | Revision 35 — 04:47, 8 Feb 2025 CDMO_Caradoc (talk) attribute range as a review estimate per talk 8,331 bytes +420 | ||
|---|---|---|---|
| 56 | Narrower dispersion across a concentrated analyte set is a more interpretable observation than a similar figure across a broad one, because fewer of the differences between reports are attributable to different chemistries and different methods.{{r|usp1503}} It remains subject to the general limitation: purchaser-submitted, purchaser-selected samples, no documented [[Chain of custody|chain of custody]], and therefore no claim about output.{{r|reports,iso17025}} | 56 | Narrower dispersion across a concentrated analyte set is a more interpretable observation than a similar figure across a broad one, because fewer of the differences between reports are attributable to different chemistries and different methods.{{r|usp1503}} It remains subject to the general limitation: purchaser-submitted, purchaser-selected samples, no documented [[Chain of custody|chain of custody]], and therefore no claim about output.{{r|reports,iso17025}} |
| 57 | 57 | ||
| + | 58 | Where certificates in this set stated a method, purchaser reports running comparable conditions have agreed closely; where they did not, the ordinary spread attributable to different separations appears.{{r|reports}} That contrast within a single organisation's report set is the clearest illustration on this wiki of how much of the apparent disagreement between purity figures is methodological rather than material. | |
| + | 59 | ||
| 58 | == References == | 60 | == References == |
| 59 | {{reflist}} | 61 | {{reflist}} |